GLPBio

SANT-1

Catalog No.: GC15889Purity:>99.50%
SANT-1 ، مضاد Smo قوي ، يمنع إشارات القنفذيظهر SANT-1 IC50s من 20 نانومتر و 30 نانومتر في مقايسة Shh-LIGHT2 و SmoA1-LIGHT2 ، على التوالي

المنتجات مخصصة للاستخدام البحثي فقط، وليست للاستخدام البشري. نحن لا نبيع للمرضى.


SANT-1
Cas No.: 304909-07-7
10mM (in 1mL DMSO)In Stock
$46.00
1
1mgIn Stock
$17.00
1
5mgIn Stock
$42.00
1
10mgIn Stock
$70.00
1
25mgIn Stock
$143.00
1
50mgIn Stock
$245.00
1
100mgIn Stock
$350.00
1

المراجع (Citations)

لا تتوفر حاليًا مراجع لهذا المنتج. فيما يلي مجموعة مختارة من المنشورات التي تستشهد بمنتجات GlpBio.
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

الوصف (Description)

SANT-1 is a cell-permeable Smoothened antagonist that inhibits the Hedgehog pathway. SANT-1 downregulates Hh target gene expressions such as Gli1 and Ptch1 to suppress tumor cell proliferation and reduces Gli-mediated transcription by blocking the Smo downstream pathway. SANT-1 can be used for research on medulloblastoma, basal cell carcinoma, glioma, pancreatic cancer, and non-small cell lung cancer[1-4].

In vitro, treatment of ASZ001 cells with 10μM SANT-1 for 48 hours inhibited hedgehog signaling activity in the cells[5]. Treatment of A172, U87MG, and T98G cells, SVG-p12 cells, and U87MG-derived cells with 10-70μM SANT-1 for 24-48 hours decreased Gli1, Nestin, IQGAP-1, and cyclin D1 expressions, reduced the number and size of glioma stem-like spheres, and lowered proliferation ability[6]. Treatment of ammonium ferric citrate-induced HEI-OC1 cells with 10-20μM SANT-1 for 24 hours protected HEI-OC1 cells from ammonium ferric citrate-induced damage and restored intracellular iron overaccumulation after ammonium ferric citrate treatment[7].

References:
[1] Stanton BZ, Peng LF. Small-molecule modulators of the Sonic Hedgehog signaling pathway. Mol Biosyst. 2010 Jan;6(1):44-54.
[2] McGaugh EC, Nostro MC. Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors. J Vis Exp. 2017 Mar 7;(121):55265.
[3] Okolowsky N, Furth PA, Hamel PA. Oestrogen receptor-alpha regulates non-canonical Hedgehog-signalling in the mammary gland. Dev Biol. 2014 Jul 15;391(2):219-29.
[4] Chun SG, Zhou W, Yee NS. Combined targeting of histone deacetylases and hedgehog signaling enhances cytoxicity in pancreatic cancer. Cancer Biol Ther. 2009 Jul;8(14):1328-39.
[5] Dheeraj A, Rigby CM, O'Bryant CL, et al. Silibinin Treatment Inhibits the Growth of Hedgehog Inhibitor Resistant Basal Cell Carcinoma Cells via Targeting EGFR-MAPK-Akt and Hedgehog Signaling. Photochem Photobiol. 2017 Jul;93(4):999-1007.
[6] Dixit D, Ghildiyal R, Anto NP, et al. Guggulsterone sensitizes glioblastoma cells to Sonic hedgehog inhibitor SANT-1 induced apoptosis in a Ras/NFkB dependent manner. Cancer Lett. 2013;336(2):347-358.
[7] Mao H, Li X, Liao Y, et al. Restoring Iron Homeostasis via Smoothened Inhibition: A Novel Strategy Against Hearing Loss. Adv Sci. 2026;13:e20749.

البروتوكول (Protocol)

Cell experiment [1]:

Cell lines

AGS cells (human gastric cancer cell line)

Preparation Method

AGS cells were maintained in RPMI-1640 medium supplemented with 10% FBS and 1% penicillin/streptomycin at 37°C, 5% CO2. AGS cells were transfected with IKZF3 overexpression vector and treated with SANT-1 for 24h, then assessed by CCK8, colony formation, wound healing and Transwell assays.

Reaction Conditions

2mM; 24h

Applications

SANT-1 decreased cell proliferation, migration and invasion in IKZF3-overexpressing AGS cells. SANT-1 also downregulated the expressions of SMO, p-AKT, CDK4 and p-Cofilin.
References:
[1] Ali M, Baral S, Ren J, et al. IKZF3 promotes gastric cancer progression via Hedgehog signaling activation and is targetable by SANT-1. Acta Biochim Biophys Sin. 2026;58(2):369-382.

وثائق المنتج (Product Documents)

Purity:>99.50%Appearance:A solid

الخصائص الكيميائية (Chemical Properties)

رقم CAS
304909-07-7
الاسم الكيميائي
(E)-N-(4-benzylpiperazin-1-yl)-1-(3,5-dimethyl-1-phenylpyrazol-4-yl)methanimine
SMILES
CC1=C(C(=NN1C2=CC=CC=C2)C)C=NN3CCN(CC3)CC4=CC=CC=C4
الصيغة الجزيئية
C23H27N5
الوزن الجزيئي
373.5
الذوبانية
≥ 18.75mg/mL in DMSO
التخزين
Store at -20°C
إرشادات عامة
اختر مذيبًا مناسبًا وفقًا لبيانات ذوبانية المنتج. بعد التحضير، قسّم المحلول المخزون إلى أجزاء لتجنب دورات التجميد والذوبان المتكررة.
استخدم المحاليل المخزونة خلال 6 أشهر عند حفظها في -80°C، أو خلال شهر واحد عند حفظها في -20°C.
لتحسين الذوبانية، سخّن الأنبوب إلى 37°C وعرّضه للموجات فوق الصوتية لمدة مناسبة.
شروط الشحن
تُشحن عينات التقييم مع عبوات تبريد. وتُشحن الأحجام الأخرى المتاحة في درجة حرارة الغرفة، أو مع عبوات تبريد عند الطلب.

الحاسبات (Calculators)المولارية / التخفيف / الوزن الجزيئي / تحويل الوحدات / تركيبة داخل الجسم الحي / الذوبانية

g/mol

Reviews

Review for SANT-1

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%